These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 6947966

  • 1. L-glutaminase and L-asparaginase by extracorporeal route in acute lymphoblastic leukemia therapy.
    Giordano C, Esposito R, Mazzola G, Vecchio G, Pluvio M, Cirillo D, Capasso GB, Buonanno G.
    Int J Artif Organs; 1981 Sep; 4(5):244-8. PubMed ID: 6947966
    [Abstract] [Full Text] [Related]

  • 2. Enhanced effect of an L-glutamine antagonist, L-(alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, by Acinetobacter L-glutaminase-L-asparaginase.
    Holcenberg JS.
    Cancer Treat Rep; 1979 Jun; 63(6):1109-14. PubMed ID: 466650
    [Abstract] [Full Text] [Related]

  • 3. Glutaminase Activity of L-Asparaginase Contributes to Durable Preclinical Activity against Acute Lymphoblastic Leukemia.
    Chan WK, Horvath TD, Tan L, Link T, Harutyunyan KG, Pontikos MA, Anishkin A, Du D, Martin LA, Yin E, Rempe SB, Sukharev S, Konopleva M, Weinstein JN, Lorenzi PL.
    Mol Cancer Ther; 2019 Sep; 18(9):1587-1592. PubMed ID: 31209181
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A Novel l-Asparaginase with low l-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias In Vivo.
    Nguyen HA, Su Y, Zhang JY, Antanasijevic A, Caffrey M, Schalk AM, Liu L, Rondelli D, Oh A, Mahmud DL, Bosland MC, Kajdacsy-Balla A, Peirs S, Lammens T, Mondelaers V, De Moerloose B, Goossens S, Schlicht MJ, Kabirov KK, Lyubimov AV, Merrill BJ, Saunthararajah Y, Van Vlierberghe P, Lavie A.
    Cancer Res; 2018 Mar 15; 78(6):1549-1560. PubMed ID: 29343523
    [Abstract] [Full Text] [Related]

  • 7. L-asparaginase-mediated Therapy in L-asparagine Auxotrophic Cancers: A Review.
    Sindhu R, Manonmani HK.
    Anticancer Agents Med Chem; 2022 Mar 15; 22(13):2393-2410. PubMed ID: 34994334
    [Abstract] [Full Text] [Related]

  • 8. In silico engineering of L-asparaginase to have reduced glutaminase side activity for effective treatment of acute lymphoblastic leukemia.
    Ln R, Doble M, Rekha VP, Pulicherla KK.
    J Pediatr Hematol Oncol; 2011 Dec 15; 33(8):617-21. PubMed ID: 22042278
    [Abstract] [Full Text] [Related]

  • 9. Extracorporeal chemotherapy with L-asparaginase in man.
    Sampson D, Han T, Hersh LS, Murphy GP.
    J Surg Oncol; 1974 Dec 15; 6(1):39-48. PubMed ID: 4206597
    [No Abstract] [Full Text] [Related]

  • 10. Glutaminase activity determines cytotoxicity of L-asparaginases on most leukemia cell lines.
    Parmentier JH, Maggi M, Tarasco E, Scotti C, Avramis VI, Mittelman SD.
    Leuk Res; 2015 Jul 15; 39(7):757-62. PubMed ID: 25941002
    [Abstract] [Full Text] [Related]

  • 11. L-asparaginase anti-tumor activity in pancreatic cancer is dependent on its glutaminase activity and resistance is mediated by glutamine synthetase.
    Blachier J, Cleret A, Guerin N, Gil C, Fanjat JM, Tavernier F, Vidault L, Gallix F, Rama N, Rossignol R, Piedrahita D, Andrivon A, Châlons-Cottavoz M, Aguera K, Gay F, Horand F, Laperrousaz B.
    Exp Cell Res; 2023 May 15; 426(2):113568. PubMed ID: 36967104
    [Abstract] [Full Text] [Related]

  • 12. L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans.
    Riccardi R, Holcenberg JS, Glaubiger DL, Wood JH, Poplack DG.
    Cancer Res; 1981 Nov 15; 41(11 Pt 1):4554-8. PubMed ID: 6895481
    [Abstract] [Full Text] [Related]

  • 13. Cerebrospinal fluid asparagine depletion during pegylated asparaginase therapy in children with acute lymphoblastic leukaemia.
    Henriksen LT, Nersting J, Raja RA, Frandsen TL, Rosthøj S, Schrøder H, Albertsen BK, Nordic Society of Paediatric Haematology and Oncology (NOPHO) group.
    Br J Haematol; 2014 Jul 15; 166(2):213-20. PubMed ID: 24702187
    [Abstract] [Full Text] [Related]

  • 14. Bacterial glutaminase in treatment of acute leukaemia.
    Spiers AS, Wade HE.
    Br Med J; 1976 May 29; 1(6021):1317-9. PubMed ID: 773514
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Use of immobilized L-asparaginase in acrylic microparticles in an extracorporeal hollow-fiber dialyzer.
    Edman P, Nylén U, Sjöholm I.
    J Pharmacol Exp Ther; 1983 Apr 29; 225(1):164-7. PubMed ID: 6834269
    [Abstract] [Full Text] [Related]

  • 17. Rational engineering and insight for a L-glutaminase activity reduced type II L-asparaginase from Bacillus licheniformis and its antileukemic activity in vitro.
    Zhou Y, Shen J, Chi H, Zhu X, Lu Z, Lu F, Zhu P.
    Int J Biol Macromol; 2024 Feb 29; 257(Pt 2):128690. PubMed ID: 38092107
    [Abstract] [Full Text] [Related]

  • 18. Reduced antithrombin III levels during L-asparaginase therapy.
    Buchanan GR, Holtkamp CA.
    Med Pediatr Oncol; 1980 Feb 29; 8(1):7-14. PubMed ID: 6934369
    [Abstract] [Full Text] [Related]

  • 19. The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells.
    Chan WK, Lorenzi PL, Anishkin A, Purwaha P, Rogers DM, Sukharev S, Rempe SB, Weinstein JN.
    Blood; 2014 Jun 05; 123(23):3596-606. PubMed ID: 24659632
    [Abstract] [Full Text] [Related]

  • 20. Novel mutant of Escherichia coli asparaginase II to reduction of the glutaminase activity in treatment of acute lymphocytic leukemia by molecular dynamics simulations and QM-MM studies.
    Ardalan N, Mirzaie S, Sepahi AA, Khavari-Nejad RA.
    Med Hypotheses; 2018 Mar 05; 112():7-17. PubMed ID: 29447943
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.